News
CSPCY
3.980
NaN%
--
Weekly Report: what happened at CSPCY last week (0511-0515)?
Weekly Report · 2d ago
Weekly Report: what happened at CSPCY last week (0504-0508)?
Weekly Report · 05/11 10:33
Weekly Report: what happened at CSPCY last week (0427-0501)?
Weekly Report · 05/04 10:30
Weekly Report: what happened at CSPCY last week (0420-0424)?
Weekly Report · 04/27 10:34
Weekly Report: what happened at CSPCY last week (0413-0417)?
Weekly Report · 04/20 10:29
Weekly Report: what happened at CSPCY last week (0406-0410)?
Weekly Report · 04/13 10:34
Weekly Report: what happened at CSPCY last week (0330-0403)?
Weekly Report · 04/06 10:34
Weekly Report: what happened at CSPCY last week (0323-0327)?
Weekly Report · 03/30 10:34
Weekly Report: what happened at CSPCY last week (0316-0320)?
Weekly Report · 03/23 10:30
Weekly Report: what happened at CSPCY last week (0309-0313)?
Weekly Report · 03/16 10:29
Weekly Report: what happened at CSPCY last week (0302-0306)?
Weekly Report · 03/09 10:30
Weekly Report: what happened at CSPCY last week (0223-0227)?
Weekly Report · 03/02 10:29
Weekly Report: what happened at CSPCY last week (0216-0220)?
Weekly Report · 02/23 10:29
China drug licensing deals surge nearly 10-fold in value since 2021
Seeking Alpha · 02/19 18:31
Weekly Report: what happened at CSPCY last week (0209-0213)?
Weekly Report · 02/16 10:29
AstraZeneca rises as cancer drugs power Q4 beat
Seeking Alpha · 02/10 12:39
Weekly Report: what happened at CSPCY last week (0202-0206)?
Weekly Report · 02/09 10:30
Weekly Report: what happened at CSPCY last week (0126-0130)?
Weekly Report · 02/02 10:30
Weekly Report: what happened at CSPCY last week (0119-0123)?
Weekly Report · 01/26 10:30
Weekly Report: what happened at CSPCY last week (0112-0116)?
Weekly Report · 01/19 10:37
More
Webull provides a variety of real-time CSPCY stock news. You can receive the latest news about Cspc Pharmaceuti through multiple platforms. This information may help you make smarter investment decisions.
About CSPCY
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.